Literature DB >> 33439042

Regarding: "Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019".

Peter A McCullough1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33439042      PMCID： PMC7877973          DOI： 10.1080/07853890.2021.1872094

Source DB:  PubMed          Journal:  Ann Med        ISSN： 0785-3890            Impact factor:   4.709


× No keyword cloud information.
  8 in total

Review 1.  Hydroxychloroquine neuromyotoxicity.

Authors:  M Stein; M J Bell; L C Ang
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

2.  Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.

Authors:  Moussa Saleh; James Gabriels; David Chang; Beom Soo Kim; Amtul Mansoor; Eitezaz Mahmood; Parth Makker; Haisam Ismail; Bruce Goldner; Jonathan Willner; Stuart Beldner; Raman Mitra; Roy John; Jason Chinitz; Nicholas Skipitaris; Stavros Mountantonakis; Laurence M Epstein
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-04-29

Review 3.  Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.

Authors:  Peter A McCullough; Ronan J Kelly; Gaetano Ruocco; Edgar Lerma; James Tumlin; Kevin R Wheelan; Nevin Katz; Norman E Lepor; Kris Vijay; Harvey Carter; Bhupinder Singh; Sean P McCullough; Brijesh K Bhambi; Alberto Palazzuoli; Gaetano M De Ferrari; Gregory P Milligan; Taimur Safder; Kristen M Tecson; Dee Dee Wang; John E McKinnon; William W O'Neill; Marcus Zervos; Harvey A Risch
Journal:  Am J Med       Date:  2020-08-07       Impact factor: 4.965

4.  Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring.

Authors:  Archana Ramireddy; Harpriya Chugh; Kyndaron Reinier; Joseph Ebinger; Eunice Park; Michael Thompson; Eugenio Cingolani; Susan Cheng; Eduardo Marban; Christine M Albert; Sumeet S Chugh
Journal:  J Am Heart Assoc       Date:  2020-05-28       Impact factor: 5.501

Review 5.  Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review.

Authors:  C Prodromos; T Rumschlag
Journal:  New Microbes New Infect       Date:  2020-10-05

Review 6.  Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.

Authors:  Pankaj Bansal; Amandeep Goyal; Austin Cusick; Shubham Lahan; Harpal S Dhaliwal; Poonam Bhyan; Pradnya Brijmohan Bhattad; Fawad Aslam; Sagar Ranka; Tarun Dalia; Lovely Chhabra; Devang Sanghavi; Bhavin Sonani; John M Davis
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

7.  COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.

Authors:  Roland Derwand; Martin Scholz; Vladimir Zelenko
Journal:  Int J Antimicrob Agents       Date:  2020-10-26       Impact factor: 15.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.